Skip to main content
Clinical Trials/NCT01207531
NCT01207531
Unknown
Not Applicable

miRNA in the Evaluation of the Value of Sepsis Prognosis Prospective Observational Study

Chinese PLA General Hospital1 site in 1 country100 target enrollmentJuly 2010
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Chinese PLA General Hospital
Enrollment
100
Locations
1
Primary Endpoint
all cause mortality
Last Updated
15 years ago

Overview

Brief Summary

Sepsis is a common cause of death in intensive care unit, timely and accurate diagnosis and treatment directly affect the survival rate. MiRNA is a post-transcriptional small RNA which regulate mRNA expression. The present study was designed to screen several miRNA by microarray which evaluate the sepsis prognosis in order to be a new target for the treatment of sepsis.

Detailed Description

The study is a non-intervention, prospective observational study. Purpose of this sudy is to screening several miRNAs by microarray which can evaluate the prognosis of sepsis . We will collect serum samples from patients with sepsis in SICU, RICU and EICU of 301 Hospital since September 2009 , and then use the chip and qRT-PCR to Screen miRNAs which can evaluate the prognosis of sepsis, and statistical analysis the miRNAS expression correlation with SOFA score.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
April 2011
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of sepsis
  • Patients who agree with the study

Exclusion Criteria

  • Aged \<18 years;
  • Into the group who died within 24 hours;
  • Agranulocytosis (\<0.5 × 109 / L);
  • Combined HIV infection.

Outcomes

Primary Outcomes

all cause mortality

Time Frame: 28days after admited in ICU

Study Sites (1)

Loading locations...

Similar Trials